logo-altasciences

EN - Main navigation

  • Proactive Drug Development
  • Solutions
  • Compare Us
  • Facilities
  • About Us
  • Resource Center
  • Careers
  • News & Events
  • 30th Anniversary Celebration
  • Contact Us
  • Participate in a study
Français
  • Home

Search results

Share this page

  • ISSUE NO. 42 — Managing The Complexities of Glucagon-Like Peptide-1 Receptor Agonist Drug Development

    Nov 1, 2024

    • End-to-End Program
    • Preclinical Research
    • Clinical Trials
    • Bioanalysis
  • ISSUE NO. 31 — The Advantages of Conducting Early-Phase Clinical Research in Canada

    Feb 13, 2023

    • Regulatory Affairs
  • Blog

    Altasciences at ASGCT 2025: An Open Forum for All Things Gene and Cell Therapy | By Kaylyn Koenig

    Jul 10, 2025

    Explore advancements in cell and gene therapy studies, like NHP research models and germline integration, as Kaylyn Koenig, Principal Scientist at Altasciences, shares highlights from attending ASGCT 2025.

    • Preclinical Research
  • Scientific Publication

    CNS Drug Development Solutions, Simplified.

    Jun 23, 2025

    • End-to-End Program
  • Blog

    Up Close and Personal with Jason Boehme, Associate Director, Program Management

    Oct 15, 2024

  • Blog

    Up Close and Personal With Eryn Corriveau, MSc, Senior Director, Drug Development and Regulatory Strategy

    Mar 27, 2024

  • Scientific Publication

    Regulatory Comparisons for Starting First-In-Human Clinical Trials

    Jan 11, 2024

    • Clinical Trials
    • Preclinical Research
    • Regulatory Affairs
  • Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next page

Sign up for exclusive content

Join our list of 30,000+ VIP members and have access to our exclusive content.

Stay connected

  • linkedin
  • youtube

Footer

    • Solutions

      • Preclinical Services
      • Clinical Services
      • Manufacturing and Analytical Services
      • Bioanalytical Services
      • Research Support Services
      • Development Programs
    • News & Events

      • Altasciences Events
      • Press Releases
      • Altasciences in the News
      • Press Kit
    • Resource Center

      • The Altascientist
      • Webinars/Podcasts
      • Newsletters
      • Scientific Publications
      • Blog
      • Videos
    • Study Types

      • Preclinical
      • Lead Optimization
      • Dose Range Finding​
      • Preclinical Pharmacology
      • Pharmacokinetics/​Pharmacodynamics
      • Cell and Gene Therapy
      • Pivotal Toxicology
      • Safety Pharmacology
      • Immunotoxicology/Immunology
      • Clinical
      • First in Human
      • Proof of Concept
      • Bioavailability/Bioequivalence
      • Pharmacokinetics in Special Populations
      • Human Abuse Potential
      • Driving Simulation
      • QT Assessment
      • Renal and Hepatic Impaired
      • Imaging
      • Biologics​/​Biosimilars
    • Therapeutic Areas

      • Cardiology
      • Dermatology
      • Gastroenterology
      • Hematology
      • Immunology
      • Infectious Diseases
      • Metabolism and Endocrinology
      • CNS/Neurology
      • Oncology
      • Ophthalmology
      • Orthopedics
      • Psychiatry
      • Respirology
      • Rheumatology
      • Substance Abuse
      • Urology
      • Women’s Health
    • About us

      • History
      • Our Origins
      • Awards
      • Testimonials
    • Careers

    • Contact Us

    • Locations

    • Stay connected

      • Facebook
      • Youtube

2025 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy

Have a question?

I'd be happy to help.

Captcha is required.